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Pulmonary resection has been established as the treat- 
ment of choice for localized non-small-cell broncho- 
genic carcinoma in the healthy patient. Usually this 
entails lobectomy, but in certain circumstances, particu- 
larly when the tumor extends beyond the lobar bron- 
chial orifice into the main bronchus, standard lobec- 
tomy will not accomplish a complete resection. Although 
pneumonectomy has traditionally been the alternative 
in this circumstance, sleeve lobectomy (lobectomy that 
involves resection of a segment of the main bronchus in 
continuity with that lobe) represents another logical 
option. Early reports of sleeve lobectomy in lung cancer 
proposed this technique as a compromise procedure in 
those patients whose pulmonary reserve was poor and 
insufficient to tolerate pneumonectomy.' However, sub- 
sequent published data have established that sleeve 
lobectomy in lung carcinoma is associated with lower 
morbidity and mortality than pneumonectomy (and, in 
fact, approaching that of standard lobectomy), a cure 
rate equivalent to that of pneumonectomy, and preser- 
vation of lung function commensurate with the conserva- 
tion of lung parenchyma in the operated hemithorax. 
The first description of conservative resection of the 
bronchial tree was by Sir Clement Price-Thomas.2 In 
his report, Price-Thomas lamented having performed a 
left pneumonectomy in a young patient with a left 
upper-lobe bronchial adenoma in 1946. Therefore, in 
1947, he performed a right upper-lobe sleeve lobectomy 
in a young royal air force cadet who would have been 
discharged from military service had he undergone 
pneumonectomy. Interestingly, Price-Thomas did not 
report these achievements until 1955.* Subsequently, 
there were other instances of sleeve resection for benign 
disease in the late 1940s and early 1950s. Sleeve 
lobectomy for lung carcinoma was promoted in the 
United States by Paulson et al,'.3 mainly as a compro- 
mise procedure. In  recent years, the notion of sleeve 
lobectomy in bronchogenic carcinoma has gained popu- 
larity, and in contemporary series, this procedure 
comprises 5% to 10% of elective lobectomies for lung 
carcinoma. 
Patient Selection and Preoperative Evaluation 
Traditionally, sleeve lobectomy for lung cancer was only 
proposed for patients who were elderly, or who had 
poor pulmonary function, notably where the predicted 
postoperative forced expiratory volume in 1 second 
(FEVI) was less than 1 L. Essentially, these circum- 
stances indicated situations in which pneumonectomy, 
the most common alternative to standard lobectomy, 
posed a very high risk. Although these continue to 
constitute solid indications for sleeve lobectomy, sleeve 
resections should also be considered in virtually any 
situation that is anatomically favorable. These may be 
summarized as the following: (1) bronchoscopic evi- 
dence of endobronchial tumor extending to or beyond 
the lobar bronchial orifice into the main bronchus; (2) 
the presence of metastatic peribronchial (lobar) lymph 
nodes infiltrating the bronchial wall at its origin; (3) or  
the finding of a positive bronchial margin after an 
apparently straightforward standard lobectomy. The 
preoperative bronchoscopy is one of the most important 
parts of the evaluation, suggesting the possible need for 
sleeve lobectomy. The bronchoscopic findings should be 
carefully reviewed in conjunction with the computed 
tomographic (CT) scan of the chest. 
Ultimately, the suitability of sleeve lobectomy is 
confirmed at surgery. In  addition to preoperative verifi- 
cation of the above favorable anatomic features, sleeve 
lobectomy is feasible only when the bronchial and 
vascular structures to the remaining lobes or  segments 
are free of disease. Therefore, the presence of bulky 
peribronchial carcinoma enveloping the main bronchus 
or  invading the pulmonary artery, or  the finding of 
metastatic lymph nodes adherent to the pulmonary 
artery within the fissure are contraindications to pursu- 
ing a sleeve lobectomy. In  these circumstances, pneumo- 
nectomy is the procedure of choice. 
Patient evaluation begins with a careful clinical 
assessment, including history and physical examina- 
tion. Clinical evaluation seeks out symptoms or physical 
signs suggestive of metastatic carcinoma. Clinical evalu- 
ation also assesses the patient's cardiopulmonary status 
by questioning for symptoms of cardiac disease and 
regarding exercise tolerance. 
Other imaging studies to achieve distant staging are 
occasionally indicated. These include CT or magnetic 
resonance scanning of the brain and radionuclide bone 
scanning. Because previously published reports failed 
to support the cost-effectiveness of routine multi-organ 
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staging scans in lung cancer,4 these additional studies 
are only obtained if there are clinical features raising 
concern about brain or bone metastases. 
If the patient has symptoms consistent with coronary 
artery disease, a documented previous myocardial in- 
farction, or an abnormal electrocardiogram, then for- 
mal cardiac evaluation is indicated before thoracotomy 
and pulmonary resection. All patients should undergo 
preoperative pulmonary function testing with careful 
attention to the FEVl and arterial blood gas obtained on 
room air. Despite the fact that the planned procedure 
may be sleeve lobectomy, operative findings may dictate 
the necessity for pneumonectomy, and therefore, the 
preoperative evaluation should be conducted with this 
in mind. Thus, if the preoperative FEVl is significantly 
less than 2 L, or if the predicted postoperative FEVl is 
less than or equal to 1 L, then quantitative ventilation- 
perfusion scintigraphy is necessary to evaluate the 
suitability of pneumonectomy in this patient. Typically, 
the presence of significant obstructive atelectasis or 
pneumonitis on the side of the carcinoma will result in 
the preponderance of both ventilation and perfusion 
being distributed to the contralateral lung. 
It is the investigator’s preference to use cervical 
mediastinoscopy in virtually every case of known or 
strongly suspected lung carcinoma. However, left ante- 
rior mediastinotomy, to evaluate subaortic (level 5) 
lymph nodes is used selectively. This selective approach 
is based on the data from Patterson et al,j which shows 
a more favorable survival rate for completely resected 
left upper-lobe carcinomas in which the only site of 
mediastinal spread was the subaortic nodes. Therefore, 
if the cervical mediastinoscopy shows no evidence of 
superior mediastinal lymph node metastases, left ante- 
rior mediastinotomy should be performed only if the 
technical feasibility of resection is in question. It is 
preferable that the mediastinoscopy be conducted un- 
der the same anesthetic as the thoracotomy and sleeve 
resection. This is performed to avoid the fibrosis and 
fixation that can develop around the proximal main 
bronchi within 1 to 2 weeks of cervical mediastinoscopy 
with an associated loss of mobility. This concern applies 
more to right upper-lobe tumors than to left-sided 
tumors. 
A very important part of the preoperative prepara- 
tion of the patient for surgery is the bronchoscopic 
evaluation of the tumor and of the remainder of the 
lung. The diagnostic and therapeutic significance of this 
evaluation is shown in this next case. The posterior- 
anterior (PA) and lateral chest radiograph of a patient 
ultimately found to be a suitable candidate for left 
upper-lobe sleeve lobectomy is shown in Figure I. The 
patient underwent thoracic surgical evaluation approxi- 
mately 2 weeks after this radiograph was obtained. At 
the time of this evaluation, the patient was experiencing 
increasing shortness of breath and also fever, chills, 
Fig I. PA (left) and lateral chest (right) radiograph of a 43-year-old man. There is a left hilar mass with 
associated volume loss of the left lung. Note the rounded opacity causing a cutoff in the distal left main 
bronchus. 
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and purulent and bloody sputum. By this time, the 
patient’s chest radiograph showed further volume loss 
and obstructive pneumonitis of the left lung (Figure 11). 
Appearance of selected cuts from the chest CT scan are 
shown in Figure 111. Addition of rigid bronchoscopy 
allowed coring out of the majority of the endobronchi- 
ally visible tumor. This served to confirm that the tumor 
did in fact originate in the left upper lobe, and that the 
lower lobe was free of disease. More importantly, a large 
amount of purulent secretions were cleared from the 
left lower lobe by resolving the bronchial obstruction. 
This led to considerable improvement in the chest 
radiographic appearance (Figure IV), and was associated 
with significant clinical improvement. This sequence of 
radiographs serves to underscore the importance of 
relieving obstruction of the bronchus to the lobes being 
preserved. Relief of obstruction, along with the institu- 
tion of appropriate intravenous antibiotics and chest 
physical therapy, will minimize the incidence of postop- 
erative pneumonia and other septic complications. 
Fig 11. PA chest radiograph of the same patient obtained at  the 
time of thoracic surgical evaluation, approximately 2 weeks after 
the radiograph shown in Fig I. The patient presented with features 
of shortness of breath and cough, which were productive of blood 
stained purulent sputum. Note once again the large left hilar mass, 
now with worsening opacification of the left lung and further 
volume loss in the left hemithorax, with leftward mediastinal shift. 
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Fig 111. Images from chest CT scan examination of this patient. (A) Hilar mass 
causing cutoff in the distal left main bronchus, associated with left upper lobe 
collapse and significant left-sided volume loss. (B) is the next most caudal cut. This 
shows similar findings, but also shows a patent left lower lobe bronchus. The mass 
protrudes from the atelectatic left upper lobe into the distal left main bronchus. 
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Fig IV. PA chest radiograph of the same patient after undergo- 
ing rigid bronchoscopy and core out of the obstructing bronchial 
mass. Note the improved expansion of the left lung, the patent air 
column within the left bronchial tree, and the return of the 
mediastinal structures to the mid-line. 
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SURGICAL TECHNIQUE 
1 Before entering the operating room, the patient has had 
placement of a lumbar epidural catheter for postoperative pain 
control. After completion of the cervical mediastinoscopy, the 
endotracheal tube is replaced with a left endobronchial (Robert 
Shaw) tube. Other monitoring modalities include a radial arterial 
line and Foley catheter. A standard posterolateral thoracotomy 
incision is made and the chest is entered in the fifth intercostal space. 
A short plug of the posterior aspect of the sixth rib can be excised to 
improve the exposure. Although standard lobectomies for small 
peripheral carcinomas can be routinely accomplished through lim- 
ited muscle sparing incisions, it is preferable to adhere to the 
standard posterolateral thoracotomy approach for sleeve lobectomy 
because of the superb exposure it affords. 
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2 Once the thoracotomy is completed and proper exposure is afforded by placing the chest 
retractors, the inferior pulmonary ligament is divided. A careful inspection is made to verify the 
absence of any intrathoracic metastatic spread on the visceral or parietal pleura. The posterior 
mediastinal pleura is opened in a cephalad direction beginning at the inferior pulmonary vein. 
This is continued so that the pleura is completely opened within the concavity of the aortic arch. 
A systematic sampling of lymph node stations is then commenced. This includes sampling of 
nodes from the inferior pulmonary ligament (level 9) and also from the subaortic space (level 5) .  
Care must be taken in the subaortic space to avoid traction or cautery injury to the left recurrent 
laryngeal nerve. All sampled lymph nodes are sent for frozen section analysis. 
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3 The pulmonary dissection attempts to achieve complete isolation of the arterial, venous, and 
bronchial structures to the upper and lower lobes. The pulmonary artery is identified and it’s 
perivascular plane is entered. The dissection is then carried down the major fissure exposing the 
upper lobe branches of the pulmonary artery. The branches to the lower lobe (superior segment 
branch and basilar trunk) are also identified. 
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4 (A-B) All upper lobe arterial branches are then divided between 2-0 silk ligatures. 
Occasionally, a bulky central left upper-lobe tumor, metastatic or granulomatous involvement 
of the peribronchial lymph nodes, will encroach on these upper lobe arterial branches. In 
these circumstances, the left main pulmonary artery must be isolated at the site of exit from the 
pericardium. The pulmonary artery is then clamped proximal and distal to the site of tumor or 
nodal adherence. 
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4 (continued) (C) A tangential excision of its wall may be necessary. The resultant arterial defect 
is then repaired directly with a continuous suture of 5-0 Prolene (Ethicon, Inc, Somerville, NJ), or 
alternatively with a pericardial patch secured in place with continuous 5-0 Prolene. 
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5 The superior pulmonary vein is isolated and divided between applications of the vascular 
stapling device. Any residual incomplete major fissure is completed at this point using the linear 
stapling instrument. The left upper lobe is now pedicled only on its bronchus. At this point, the 
procedure has been identical to that of standard lobectomy. Careful inspection and palpation of the 
origin of the upper lobe bronchus will confirm the feasibility of sleeve lobectomy. All interlobar 
lymph nodes in the crotch between the upper and lower lobe bronchi (level 11) are excised and 
submitted for frozen section analysis. Similarly, nodes are sampled along the course of the left main 
bronchus. This includes left tracheobronchial angle lymph nodes (level 10) and also subcarinal 
lymph nodes (level 7). Once the frozen section result has confirmed absence of lymph node 
metastases, the sleeve resection and anastomosis are undertaken. 
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6 Division of the bronchus is performed using a scalpel to ensure a neat transection site. The 
initial transection is in the distal left main bronchus several millimeters proximal to the upper lobe 
origin. The lumen is then carefully inspected to verify a tumor-free proximal bronchial margin. 
Using a small Yankauer suction tip passed down into the lower lobe bronchus, the site of distal 
bronchial transection is selected. In a similar manner, the bronchus is transsected distally with a 
scalpel, and the adequacy of the distal margin is evaluated grossly. If grossly the proximal and distal 
margins seem satisfactory, preparations are made to begin the bronchial anastomosis. The sleeve 
lobectomy specimen is submitted for frozen section evaluation of the proximal and distal bronchial 
margins. 
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7 It  is essential that the bronchial anastomosis be created without tension. In this 
regard, the inferior hilar release is an important component of the procedure. The 
pericardium around the inferior pulmonary vein is completely incised in a U-shaped 
manner. This facilitates upward mobility of the left lower lobe, and allows the hilum to 
come up by 1 to 2 cm. 
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8 The bronchial anastomosis is then created using a series of interrupted 4-0 Vicryl 
sutures (Ethicon, Inc, Somerville, NJ) passed through mineral oil. (A) Sutures are placed 
precisely approximately 2 mm apart and 2 mm from the cut edge of the bronchus. (B) 
Distance between sutures on the proximal and distal bronchial margins should be 
determined according to any size discrepancy between the two lumens. Any significant size 
disparity can subsequently be accommodated for with the highly pliable membranous 
bronchus. 
L UPPER LOBE SLEEVE RESECTION 197 
8 (continued) Creation of the anastomosis is facilitated by the forward retraction of the 
pulmonary artery, therefore, that the bronchial anastomosis is created behind the artery. 
(C) After careful and sequential placement of all the sutures, the bronchial edges are 
gently approximated without tension and the sutures are tied. The anastomosis is 
immersed in warm saline, and manual ventilation of the left lung is commenced; it should 
be air tight despite 20 cm-water-sustained manual pressure. 
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9 The bronchial anastomosis is always wrapped with a pedicle of healthy tissue. In a left 
upper-lobe sleeve lobectomy, a very convenient pedicle is the anterior pericardial fat pad. This 
fat pad is harvested beginning near the diaphragm and staying anterior to the phrenic nerve. It is 
mobilized in a cephalad direction so that it remains pedicled proximally. This flap of tissue has 
sufficient bulk and mobility to wrap it around the bronchial anastomosis without difficulty. It is 
then tacked loosely into place with interrupted 4-0 silk sutures. 
The procedure has essentially been completed. Verifi- 
cation of negative proximal and distal margins must be 
confirmed before the patient is awakened from the 
anesthesia. After securing proper hemostasis and irriga- 
tion of the chest with warm saline, two 28F chest tubes 
are positioned appropriately within the pleural space. 
The thoracotomy is then closed in standard fashion, 
using number 2 Vicryl (Ethicon, Inc) for pericostal 
sutures, number 1 Vicryl in the extracostal muscle 
layers, 2-0 Vicryl in subcutaneous tissues, and 4-0 
Vicryl for subcuticular skin closure. 
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Postoperative Care 
Data from previous publications have suggested the 
development of ipsilateral lung dysfunction after sleeve 
lobectomy in animals6 and  human^.^ This lung dysfunc- 
tion is associated with secretion retention, and mani- 
fests also with impaired gas exchange. For this reason, 
several previous investigators have recommended the 
liberal use of periodic bedside fiberoptic bronchoscopy 
in the routine postoperative care of the sleeve lobec- 
tomy patient.* However, with modern techniques of 
anesthesia, perioperative pain control, and intensive 
physical therapy, the care of the sleeve lobectomy 
patient does not differ substantially from that of the 
patient undergoing standard pulmonary lobectomy, 
and routine fiberoptic bronchoscopy is not necessary. 
Intravenous fluids are limited on the night of surgery 
and are stopped the next morning when oral intake is 
resumed. Supplemental oxygen is administered by nasal 
prongs, and then weaned as tolerated, based on clinical 
status and pulse oximetry. Pain control is achieved 
through a lumbar epidural catheter placed preopera- 
tively. This epidural catheter is retained for 48 to 72 
hours postoperatively, and then removed and replaced 
with a patient controlled analgesia pump or oral analge- 
sic tablets. Physical therapy, consisting of chest percus- 
sion and postural drainage, is commenced the morning 
after the procedure, and ambulation is begun the 
afternoon of the first postoperative day. Chest tubes are 
maintained at -20 cm of water suction and converted to 
water-seal drainage when no air leak is discernable. The 
chest tubes may then be removed when fluid drainage is 
also minimal. The significant majority of patients are 
ready for discharge from the hospital by the 4th or 5th 
postoperative day. Fiberoptic bronchoscopy (under 
topical anesthesia) should be performed to inspect the 
anastomosis before hospital discharge. At this point, the 
anastomosis should show evidence of satisfactory heal- 
ing. Although there may be minimal fibrinous exudate 
along the suture line, there should be no mucosal slough 
or separation noted. The 4-month-postoperative-chest 
radiograph of the patient depicted earlier (Figures I-IV) 
is shown in Figure V. The bronchoscopic appearance of 
the well-healed bronchial anastomosis after left upper- 
lobe sleeve lobectomy in this patient is shown in 
Figure VI. 
Fig V. PA chest radiograph of the same patient obtained 4 
months after left upper-lobe sleeve lobectomy. Final pathology 
report showed this to be a moderately differentiated adenocarci- 
noma with negative lymph nodes. The chest radiograph is 
satisfactory, and shows good expansion of the left lower lobe. 
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Fig VI. 
tomosis after left upper-sleeve resection in the same patient. 
Bronchoscopic appearance of the well-healed bronchial anas- 
L UPPER LOBE SLEEVE RESECTION 201 
COMMENTS 
When used for appropriate indications, sleeve lobec- 
tomy achieves excellent results rivaling those of pneumo- 
nectomy with respect to operative mortality and late 
survival. Available data also show that sleeve lobectomy 
is superior to pneumonectomy by virtue of its preserva- 
tion of lung tissue. 
Tedder et a19 published a collective review of 1,915 
bronchoplastic procedures for malignancy reported 
between 1980 to 1992, and evaluated 30-day mortality, 
the complication rate, and late survival. They noted a 
30-day mortality of 6211,125 sleeve lobectomies, or 
5.5%. In a report dealing with their institutional 
experience with 145 sleeve resections for carcinoma, 
Van Schil et allo reported a 4.8% operative mortality. 
Similarly, Gaissert et all1 summarized the Massachu- 
setts General Hospital experience with 72 sleeve lobecto- 
mies for lung cancer spanning 3 decades, and reported 
a 4% operative mortality. These figures compare favor- 
ably with the 6.2% operative mortality for elective 
pneumonectomy in lung cancer, as reported by the 
Lung Cancer Study Group in 1983.12 In the report by 
Tedder et al, the main sources of morbidity after sleeve 
lobectomy for carcinoma were pneumonia, persistent 
atelectasis, and anastomotic stenosis (Table 1). Broncho- 
vascular fistula is a rare yet lethal complication of 
sleeve lobectomy, and was reported in 2.5% of the cases 
that comprised their collective re vie^.^ The creation of 
a tension-free bronchial anastomosis and wrapping the 
anastomosis with a pedicle of healthy tissue remain the 
best maneuvers for avoidance of this dreaded complica- 
tion. 
The adequacy of sleeve lobectomy as a cancer opera- 
tion in bronchogenic carcinoma must also be evaluated. 
In their collective review, Tedder et a19 found local 
recurrence to be reported in 84 of 673 sleeve lobecto- 
mies (12.5%). Gaissert et all’ reported local recur- 
rences in 10 of 69 sleeve lobectomies (14%). The 5-year 
survival in the collective review by Tedder et a1 was 
2451614 (40%). However, when late survival was strati- 
fied by stage, it was found to be 63% for stage I, 37% 
for stage 11, and 21% for stage 111. Tedder et a1 point 
out that only approximately one third of the patients 
who comprised this collective review were staged preop- 
eratively. Therefore, the predicted 5-year survival for 
standard lobectomy, if corrected based on the percent- 
age of patients staged preoperatively, was 58% for stage 
I, 37% for stage 11, and 22% for stage 111. Similar 
survival rates have been reported by other authors. 
Van Schil et allo reported a 59% 5-year survival rate 
after sleeve lobectomy in stage I lung cancer, and 42% 
in stage 11. Gaissert et a1 similarly noted a 57% 5-year 
survival after sleeve lobectomy in stage I and 38% in 
stage 11. As expected, the presence or absence of lymph 
node metastases profoundly affected late survival in all 
of these ~tudies,~-ll  and in the collective review by 
Tedder et al, 5-year survival after sleeve lobectomy for 
NO lung cancers was 60%. 
Another important aspect of sleeve lobectomy for 
bronchogenic carcinoma is the preservation of lung 
parenchyma that would otherwise be sacrificed if the 
alternative standard procedure, pneumonectomy, were 
performed. Unfortunately, there has been rather scanty 
documentation of the preservation of pulmonary func- 
tion after sleeve lobectomy. This may be partly related 
to the fact that the greatest increase in implementation 
of this procedure has occurred only within the past 
d e ~ a d e . ~  Gaissert et all1 used pulmonary function 
testing and quantitative ventilation-perfusion scintigra- 
phy before and after sleeve lobectomy for lung cancer to 
evaluate this issue. From their review of 72 sleeve 
resections, 16 patients had postoperative spirometry (at 
a mean interval of 3.5 years after sleeve lobectomy) in 
addition to the routine preoperative spirometry. These 
investigators also used the preoperative quantitative 
ventilation-perfusion lung scan to predict the postopera- 
tive FEVl. In general, comparison of the observed to 
the predicted postoperative FEVl yielded comparable 
values, with a correlation coefficient of 0.87. The 
predicted values tended to exceed the observed values 
by only about 15%. In their study, eight patients 
underwent postoperative quantitative ventilation-perfu- 
sion lung scintigraphy, at a mean interval of 4.5 years 
after sleeve lobectomy. Mean perfusion of the operated 
side was 35%, and mean ventilation was 44%. These 
impressive results support the notion that functional 
outcome is superior after sleeve lobectomy as compared 
with pneumonectomy in lung cancer patients. 
In conclusion, sleeve lobectomy has recently gained 
sigdicant popularity as a surgical option for patients 
with bronchogenic carcinoma. Although it was origi- 
nally proposed as a compromise procedure for patients 
with poor pulmonary reserve, the available modern 
TABLE 1. Morbidity After Sleeve Lobectomy for Bronchogenic Carcinoma 
Empyema Bronchopleural Bronchovascular Pulmonary Pneumonia Atelectasis Anastomotic 
(“w (“/4 Stenosis (“/o) Fistula (%) Fistula (%) Embolism ( “ 7 )  (“4 
9.9 5.2 4.8 3.0 2.5 2.3 2.0 
NOTE. Taken from collective review of 1,915 reported sleeve resections for lung cancer by Tedder et aL9 
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data support its use whenever the anatomic location of 
the tumor or involved lymph nodes are favorable. 
Recent series show that sleeve lobectomy is associated 
with a lower operative mortality compared with pneumo- 
nectomy in a similar group of patients. Available data 
also show that late survival after lung cancer resection 
by sleeve lobectomy is comparable with that for simi- 
larly staged tumors treated by standard lobectomy. 
With modern techniques of anesthesia and peri- 
operative care of the pulmonary resection patient, the 
management of the patient undergoing sleeve lobectomy 
does not generally pose any unusual difficulties. Careful 
preoperative evaluation and attention to selected key 
technical aspects of the operation will minimize the 
incidence of serious peri-operative complications and 
ensure a good late functional result. 
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